NT Pharma surprises with low price, Hilong gets HK$1.04bn
China NT Pharma Group and Hilong Holdings closed their initial public offerings on Thursday, the first IPOs to close in Hong Kong in four weeks. Bankers both on and away from NT Pharma’s deal were surprised when it was priced at the bottom of the range, but Hilong managed to price just above the lower end of its range.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts